CURRENTLY UNDER CONSTRUCTION
In 1991, Dr. Alexander Theodore "Sasha" Shulgin and his wife Laura Ann Shulgin published PiHKAL (Phenethylamines I Have Known and Loved): A Chemical Love Story, and later publishing TiHKAL (Tryptamines I Have Known and Loved): The Continuation in 1997. Through these two works, Sasha attempted to break the boundaries of a professional laboratory setting to present the public with psychedelic and/or empathogen-entactogen chemicals that could aid in ones exploration in self-consciousness. These books both pushed drug culture by presenting a controversial (and important) side of recreational drug use, as well as putting the foundation for what would later become the research chemical market. Now you may ask, why is any of this of any importance as I'm reading this? Well, as the name shows, we will attempt to continue this powerful series with a crude, but allbeit important sequel exploring the freightening world of deliriant drugs.
According to the National Center of Biotechnology Information, delirium can be described as "an alternation of attention, consciousness, and cognition, with a reduced ability to focus, sustain, or shift attention". So put into this context, a deliriant drug would be any substance which active chemical(s) put the user in an active state of delirium. Keep in mind, these are drugs that directly can cause the user to experience such effects. This means that something such as stimulants (which if binged, can cause the user to experience sleep deprivation which can put them into a state of delirium) cannot be classified as such because their chemical makeup and receptor activity is not the direct cause of delirium, simple enough yeah?
| # | PAGE | INFO |
| 1 | Chemical Classes | Exploring the individual classes in which these substances fall into, their mechinism of action, and more. |